# Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)

> **NCT01434849** · PHASE1 · TERMINATED · sponsor: **Alice K. Gong** · enrollment: 26 (actual)

## Conditions studied

- Infantile Hemangioma
- Very Low Birth Weight Infants

## Interventions

- **DRUG:** topical 0.5% Timolol maleate
- **DRUG:** Control (placebo) group

## Key facts

- **NCT ID:** NCT01434849
- **Lead sponsor:** Alice K. Gong
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** Difficulty with enrolled patients to complete trial.
- **Last updated:** 2016-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01434849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01434849, "Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT01434849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*